Ingevity Co. (NYSE:NGVT) Stake Reduced by Yousif Capital Management LLC

Yousif Capital Management LLC reduced its stake in shares of Ingevity Co. (NYSE:NGVT) by 1.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,713 shares of the company’s stock after selling 235 shares during the quarter. Yousif Capital Management LLC’s holdings in Ingevity were worth $559,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in NGVT. State Street Corp boosted its position in Ingevity by 14.7% during the 3rd quarter. State Street Corp now owns 1,546,957 shares of the company’s stock worth $60,331,000 after acquiring an additional 198,300 shares during the period. Thrivent Financial for Lutherans boosted its position in Ingevity by 1.7% during the 3rd quarter. Thrivent Financial for Lutherans now owns 1,383,053 shares of the company’s stock worth $53,939,000 after acquiring an additional 23,497 shares during the period. Segall Bryant & Hamill LLC boosted its position in Ingevity by 33.5% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 1,185,415 shares of the company’s stock worth $46,231,000 after acquiring an additional 297,135 shares during the period. Royce & Associates LP boosted its position in Ingevity by 23.3% during the 3rd quarter. Royce & Associates LP now owns 933,677 shares of the company’s stock worth $36,413,000 after acquiring an additional 176,447 shares during the period. Finally, Geode Capital Management LLC boosted its position in Ingevity by 4.3% during the 3rd quarter. Geode Capital Management LLC now owns 815,661 shares of the company’s stock worth $31,817,000 after acquiring an additional 33,973 shares during the period. 91.59% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, BMO Capital Markets boosted their price target on Ingevity from $40.00 to $47.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Ingevity currently has an average rating of “Moderate Buy” and an average price target of $52.17.

Ingevity Trading Down 0.4 %

Shares of Ingevity stock opened at $45.01 on Monday. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 6.52. The firm has a market cap of $1.64 billion, a price-to-earnings ratio of -2.90 and a beta of 1.64. The business has a fifty day simple moving average of $43.34 and a 200-day simple moving average of $40.88. Ingevity Co. has a fifty-two week low of $30.90 and a fifty-two week high of $56.29.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.